Thilo Schaufler
Strategic Advisor in Market Access, HEOR & Health Policy
Zug, Zug, Switzerland · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
Today, scientific progress only matters if it can navigate the complex internal and external barriers to patient access. I help Biopharma leaders bridge the gap between compelling evidence, launch readiness, and commercial impact. I act as a Strategic Catalyst, helping you clarify strategic choices, align cross-functional teams, and accelerate evidence-driven decisions. My goal is to ensure your strategies stand up to both payer scrutiny and internal management expectations. Key Strategic Levers: - Pricing & Reimbursement Strategy: Shaping value early to craft narratives that achieve sustainable access and reimbursement. - Evidence & Publication Strategy: Turning clinical and Real-World Evidence (RWE) into coherent stories that build stakeholder confidence and ensure readiness for EU JCA. - Policy & System Engagement: Anticipating systemic shifts early to help organizations engage confidently with policy stakeholders and adapt strategies for business results. Professional Foundation: My advisory is built on 20 years of global leadership at AbbVie, Roche, and CSL Vifor. I have led successful launches across Immunology, Oncology, and Rare Diseases and co-shaped national industry stra
Experience
Jun 2025
Education
Dr. rer. pol, Economics, Health Economics
2004 to 2006
Executive Certificate, Oxford Strategic Management Executive Programme
2025 to 2025
M.A., Political Sciences, Economics
1999 to 2003